Baggio, Laurie L.

The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 mice

Forny Germano, L., Koehler, J. A., Baggio, L. L., Cui, F., Wong, C. K., Rittig, N., Cao, X., Matthews, D., & Drucker, D. J. (2024) · Molecular Metabolism

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 50

Genetic disruption of the Gipr in Apoe−/− mice promotes atherosclerosis

Pujadas, G., Baggio, L. L., Kaur, K. D., McLean, B. A., Cao, X., & Drucker, D. J. (2022) · Molecular Metabolism

Atherosclerosis and Cardiovascular DiseasesAdipokines, Inflammation, and Metabolic Diseases

Cited by 34

Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice

Fuchs, S., Yusta, B., Baggio, L. L., Varin, E. M., Matthews, D., & Drucker, D. J. (2020) · JCI Insight

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 29

Glucose-dependent insulinotropic polypeptide receptor signaling alleviates gut inflammation in mice

Hammoud, R., Kaur, K. D., Koehler, J. A., Baggio, L. L., Wong, C. K., Advani, K. E., Yusta, B., Efimova, I., Gribble, F. M., Reimann, F., et al. (2025) · JCI Insight

Diabetes Treatment and ManagementInflammatory Bowel Disease

Cited by 24